Research: CDS Tools Need Improvement to Reduce Unnecessary Imaging Costs | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Research: CDS Tools Need Improvement to Reduce Unnecessary Imaging Costs

June 2, 2015
by Gabriel Perna
| Reprints
Clinical decision support tools can lead to a reduction in the ordering of inappropriate advanced imaging tests, according to new research from the RAND Corporation. The tools just need to improve.
Researchers from RAND, a Santa Monica, Calif.-based nonprofit organization, recently looked at the effectiveness of a clinical decision support (CDS) tools in reducing the inappropriate ordering of advanced diagnostic imaging procedures for Medicare fee-for-service patients. Over a two-year period, the researchers found that the tools, computer-based programs that match a patient's characteristics against treatment criteria and recommend a treatment, increased the proportion of appropriate tests, according to the findings. 
However, the findings weren't all positive. The researchers were not able to assign appropriateness ratings for a majority of tests because there was no appropriateness criteria available or because the tool was not able to find matching criteria.
“The increase in orders rated as appropriate is promising, but the number of tests that were not rated indicates there is room for further improvement of these tools,” Peter S. Hussey, a senior policy researcher at RAND, said in a statement. “In our full report to Congress, we’ve outlined a series of improvements to the decision support tools that we expect can lead to greater reductions in unnecessary tests.”
Those improvements, they say, include a more-comprehensive set of evidence-based guidelines that cover a greater proportion of advanced imaging orders for Medicare patients.
For the study, 3,340 clinicians placed 117,348 orders for advanced diagnostic imaging procedures. The participating organizations were located in eight states and included three academic medical centers, two integrated delivery systems, one group of independent practices in a single geographic area and one group of independent practices recruited by a radiology benefits management organization.
The findings were published in the Journal of the American Medical Association. The Centers for Medicare and Medicaid Services sponsored the study. Beginning in 2017, federal rules will require that decision support tools must be used before ordering any advanced diagnostic imaging study paid for by Medicare.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More



Healthcare Execs Anticipate High Cost Returns from Predictive Analytics Use

Healthcare executives are dedicating budget to predictive analytics, and are forecasting significant cost savings in return, according to new research from the Illinois-based Society of Actuaries.

Adam Boehler Tapped by Azar to Serve as Senior Value-Based Care Advisor

Adam Boehler, currently director of CMMI, has also been named the senior advisor for value-based transformation and innovation, HHS Secretary Alex Azar announced.

Vivli Launches Clinical Research Data-Sharing Platform

On July 19 a new global data-sharing and analytics platform called Vivli was unveiled. The nonprofit group’s mission is to promote, coordinate and facilitate scientific sharing and reuse of clinical research data.

Survey: More Effective IT Needed to Improve Patient Safety

In a Health Catalyst survey, physicians, nurses and healthcare executives said ineffective information technology, and the lack of real-time warnings for possible harm events, are key obstacles to achieving their organizations' patient safety goals.

Physicians Still Reluctant to Embrace Virtual Tech, Survey Finds

While consumers and physicians agree that virtual healthcare holds great promise for transforming care delivery, physicians still remain reluctant to embrace the technologies, according to a new Deloitte Center for Health Solutions survey.

Geisinger, AstraZeneca Partner on Asthma App Suite

Geisinger has partnered with pharmaceutical company AstraZeneca to create a suite of products that integrate into the electronic health record and engage asthma patients and their providers in co-managing the disease.